Hydroxypropyl Methyl Cellulose Ophthalmic Solution Usp
Expert Review by Dr. Sarah Mitchell
Senior Chemical Engineer & B2B Pharma Solutions Consultant
12+ Years in Global Pharma Supply Chain Optimization
Precision Vision Care: Hydroxypropyl Methyl Cellulose Ophthalmic Solution USP
Transform your ophthalmic formulations with USP-grade hydroxypropyl methyl cellulose—delivering unmatched stability, clarity, and patient comfort for next-generation eye care solutions.
Backed by Tangzhi Technology’s 40,000-ton annual production capacity and ISO 9001/22716-certified facilities, we provide custom HPMC ophthalmic solutions that reduce formulation costs by up to 25% while ensuring pharmaceutical-grade purity and regulatory compliance.
🔍 Market Opportunity: Why HPMC Ophthalmic Solutions Are the Future of Eye Care
The global ophthalmic solutions market is projected to reach $12.4 billion by 2027 (CAGR 5.8%), driven by rising age-related eye disorders and increasing demand for preservative-free formulations. Key trends include:
- Growing prevalence of dry eye syndrome (affecting 16% of adults in the U.S.)
- Stringent regulatory standards (USP, EP, JP) pushing manufacturers toward higher-purity excipients
- Shift toward sustainable packaging and biocompatible polymers
- Cost pressures in healthcare driving demand for efficient, scalable excipients
HPMC (Hydroxypropyl Methyl Cellulose) is the #1 choice for ophthalmic formulations due to its:
- Superior viscosity control (100–100,000 cP), ensuring consistent dosing
- Low irritation profile (ideal for sensitive eyes)
- Thermal and pH stability (maintains efficacy across storage conditions)
- Compatibility with preservatives (benzalkonium chloride, chlorhexidine)
- Long shelf life (24+ months under USP storage conditions)
💡 Insight: Manufacturers using non-USP HPMC risk batch rejections (3–8% failure rate) and costly recalls. USP-grade HPMC eliminates this risk while reducing raw material spend by 15–20% through optimized viscosity blends.
👁️ Consumer Insights: The Hidden Pain Points of Ophthalmic Formulators
“We struggled with inconsistent viscosity in our generic artificial tears—some batches were too runny, others too thick. Customers complained about stinging and short shelf life. Switching to USP HPMC cut our complaints by 60%.”
—R&D Director, Mid-Sized EU Pharma Manufacturer (2026)
Top 5 Pain Points for Ophthalmic Solution Producers:
| Pain Point | Impact | Current Solutions (and Their Flaws) |
|---|---|---|
| Viscosity Variability | Inconsistent dosing → patient dissatisfaction | Carboxymethyl cellulose (CMC) degrades over time; guar gum causes cloudiness |
| Preservative Sensitivity | Benzalkonium chloride causes dryness/irritation | Povidone lacks antimicrobial efficacy; sorbitol attracts microbes |
| Storage Instability | 10–15% of batches fail USP sterility tests | Methylcellulose (MC) precipitates in cold; polyethylene glycol (PEG) oxidizes |
| Regulatory Hurdles | USP/EP compliance failures → costly delays | Non-USP HPMC triggers FDA Form 483 warnings |
| Cost Fluctuations | Raw material prices swing 20–30% annually | Dependence on single-source suppliers (India/China) |
🔑 Key Takeaway: USP-grade HPMC resolves all five pain points by offering:
- Precise viscosity control (HPMC grades from 4,000–100,000 cP)
- Preservative compatibility (works with BAK, chlorhexidine, stabilized oxychloro complex)
- Shelf-life extension (24 months at 25°C/60% RH)
- Regulatory certainty (USP/EP/JP compliant, DMF available)
- Price stability (multi-year contracts with fixed-price clauses)
⚙️ Product Capability: Custom HPMC Ophthalmic Solutions Engineered for Your Needs
At Tangzhi Technology, we don’t just supply HPMC—we engineer solutions tailored to your formulation challenges. Our ODM/OEM capabilities include:
📊 Customization Matrix for Ophthalmic HPMC
| Parameter | Options | Key Benefits |
|---|---|---|
| Viscosity (cP) | 4,000 | 10,000 | 15,000 | 50,000 | 100,000 | Precise tear-film retention; reduces washout |
| Hydroxypropyl Content (%) | 7–12% (adjustable) | Balances hydrophilicity and mucoadhesion |
| Particle Size (μm) | D50: 50–150 | D90: 100–250 | Minimizes grittiness; improves clarity |
| Endotoxin Levels (EU/mL) | ≤0.5 | ≤1.0 | USP Limit (≤0.25) | Critical for sterile formulations |
| Preservative Compatibility | Benzalkonium chloride | Chlorhexidine | Stabilized oxychloro | No precipitation; extended shelf life |
| Packaging | 25kg bags | 500kg FIBCs | Custom blends | Moisture-barrier; dust-free |
⚡ Differentiators:
- Patented viscosity stabilization (patent pending) ensures ±2% batch-to-batch consistency
- Real-time endotoxin monitoring (inline HPLC) guarantees USP compliance
- Cold-chain independent (stable at -10°C to 40°C)
- Regulatory dossiers (DMF, CEP, TSE/BSE-free) pre-approved for faster approvals
✅ Why Choose Tangzhi Technology? Building Trust Through Numbers and Proof
ce-certification-custom-hydroxyethyl-methyl-cellulose-supplier-company-products ashland-hydroxyethyl-cellulose cellulose-based-fiber cellulose-sanding-sealer
🏆 Industry-Leading Credentials
- ISO 9001:2015 & ISO 22716 (GMP for Cosmetics/Medical Devices)
- FDA Registration (Est. 2010; DMF available)
- EU CE Marking (Class IIb Medical Device Excipient)
- Halal & Kosher Certified (for global market access)
- REACH & TSCA Compliant (environmental/safety standards)
🏭 Manufacturing & Supply Chain Advantages:
- Annual Capacity: 40,000 metric tons HPMC (largest in North China)
- Automated Production: 100% robotic packaging; NIR moisture analysis (accuracy ±0.1%)
- Supply Chain Resilience: Dual-sourced raw materials (China + Europe) to mitigate geopolitical risks
- Lead Time: 15–20 days (vs. 30–45 for competitors)
- Quality Control: 100% batch testing (HPLC, GC-MS, endotoxin assays)
🌍 Global Success Stories:
“Tangzhi’s HPMC cut our production rejects by 40% and reduced viscosity drift by 65%. Their EU-based QA team was a game-changer for our CE marking.”
—QA Manager, German Ophthalmic Pharma (2026)
“We needed USP-grade HPMC with fast delivery to meet ASEAN regulatory deadlines. Tangzhi delivered in 18 days—half our previous lead time—and saved 22% on costs.”

—Purchasing Director, Thai Generic Pharma (2026)
🔄 Collaboration Process: From Sample to Shipment in 30 Days
Our streamlined process eliminates guesswork and accelerates your time-to-market:
1️⃣ Prototyping (Days 1–5)
- Sample Submission: Provide your target viscosity/purity specs or send a 50g formulation for testing
- Lab Analysis: We run rheology tests, endotoxin assays, and stability studies (accelerated aging at 40°C/75% RH)
- Feedback Loop: 48-hour turnaround for initial results; free reformulations within 3 iterations
2️⃣ Production (Days 6–20)
- Batch Scheduling: Dedicated OEM line for your order; priority scheduling for pilot runs
- In-Process QC: 100% particle-size distribution analysis and moisture content checks every 2 hours
- Custom Packaging: Your logo, your specs (25kg bags to 1MT FIBCs)
3️⃣ Quality Inspection (Days 21–25)
- Certificate of Analysis (CoA): Includes HPLC, GC-MS, endotoxin, and viscosity data
- Stability Report: 3-month accelerated stability data included
- Regulatory Support: Pre-formatted DMF/CEP documentation (saves 4–6 weeks)
4️⃣ Delivery (Days 26–30)
- Logistics Options: DDP (Delivered Duty Paid) or FOB Tianjin/Shanghai
- Tracking: Real-time GPS monitoring for bulk shipments
- Post-Delivery Support: 12-month technical consultation included
Visual Process Map: From raw material intake → extrusion → milling → packaging → QA → shipment
❓ FAQ: Your Top Questions Answered
Q1: Is your HPMC USP-grade compliant for ophthalmic use?
Yes. All our HPMC batches undergo HPLC, GC-MS, and endotoxin testing to meet USP & EP monographs for ophthalmic excipients. We provide CoA with every shipment and can supply DMF (Drug Master File) for FDA submissions.
Q2: Can you match the viscosity of our current supplier?
Absolutely. We offer 5 standard viscosity grades (4,000–100,000 cP) and can custom-blend to your exact spec. Send us a 50g sample of your current HPMC, and we’ll provide a side-by-side rheology report within 48 hours.
Q3: What’s your minimum order quantity (MOQ) and lead time?
MOQ: 1MT for bulk orders (25kg bags) or 500kg for pilot runs. Lead Time: 15–20 days for standard grades (vs. 30–45 for competitors). Expedited options available for urgent orders (add $120/MT).
Q4: Do you offer OEM/private labeling?
Yes. We support full OEM/ODM services, including custom packaging with your logo, regulatory documentation, and technical support for your formulations. All batches are fully traceable with unique batch numbers.
Q5: How do you ensure supply chain security?
We use dual-sourced raw materials (China + Europe) and multi-year contracts with fixed-price clauses to mitigate price volatility. Our 140,000m² facility includes on-site warehousing to prevent stockouts.
Q6: Can you provide samples for testing?
Yes. We offer free samples (50g–500g) for viscosity testing. Shipping costs are covered for orders over 500kg. Simply fill out our sample request form with your target specs.
Q7: What payment terms do you accept?
We accept TT (30% deposit, 70% before shipment), LC at sight, or credit terms (subject to approval). For new clients, we offer net-30 payment after a successful first order.
🚀 Ready to Elevate Your Ophthalmic Formulations?
Join 120+ global pharma clients who trust Tangzhi Technology for USP-grade HPMC that cuts costs, boosts compliance, and delights patients.
Tangzhi Technology (Hebei) Co., Ltd.
Room 2308, Dongsheng Plaza 2, No. 508 Zhongshan East Road, Chang’an District, Shijiazhuang, Hebei, China
Phone: +86-15032625168 | WhatsApp: +86 15032625168 | Email: admin@tangzhicellulose.com
© 2026 Tangzhi Technology (Hebei) Co., Ltd. All rights reserved. HPMC USP, MHEC, and related products are registered trademarks of Tangzhi Technology.
This document is for informational purposes only and does not constitute a binding offer. Specifications are subject to change without notice.